AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/139
INTRANASAL SALMETEROL INHIBITS ALLERGEN-INDUCED VASCULAR-PERMEABILITYBUT NOT MAST-CELL ACTIVATION OR CELLULAR INFILTRATION
Authors: PROUD D REYNOLDS CJ LICHTENSTEIN LM KAGEYSOBOTKA A TOGIAS A
Citation: D. Proud et al., INTRANASAL SALMETEROL INHIBITS ALLERGEN-INDUCED VASCULAR-PERMEABILITYBUT NOT MAST-CELL ACTIVATION OR CELLULAR INFILTRATION, Clinical and experimental allergy, 28(7), 1998, pp. 868-875
IL-4 SECRETION AND HISTAMINE-RELEASE BY HUMAN BASOPHILS ARE DIFFERENTIALLY REGULATED BY PROTEIN-KINASE-C ACTIVATION
Authors: SCHROEDER JT HOWARD BP JENKENS MK KAGEYSOBOTKA A LICHTENSTEIN LM MACGLASHAN DW
Citation: Jt. Schroeder et al., IL-4 SECRETION AND HISTAMINE-RELEASE BY HUMAN BASOPHILS ARE DIFFERENTIALLY REGULATED BY PROTEIN-KINASE-C ACTIVATION, Journal of leukocyte biology, 63(6), 1998, pp. 692-698
EVALUATION OF VENOM SKIN-TEST SENSITIVITY - REPLY
Authors: GOLDEN DBK KAGEYSOBOTKA A LICHTENSTEIN LM
Citation: Dbk. Golden et al., EVALUATION OF VENOM SKIN-TEST SENSITIVITY - REPLY, Journal of allergy and clinical immunology, 102(4), 1998, pp. 702-703
EFFECTS OF PEPTIDE THERAPY ON EX-VIVO T-CELL RESPONSES
Authors: MARCOTTE GV BRAUN CM NORMAN PS NICODEMUS CF KAGEYSOBOTKA A LICHTENSTEIN LM ESSAYAN DW
Citation: Gv. Marcotte et al., EFFECTS OF PEPTIDE THERAPY ON EX-VIVO T-CELL RESPONSES, Journal of allergy and clinical immunology, 101(4), 1998, pp. 506-513
DISCONTINUING VENOM IMMUNOTHERAPY - EXTENDED OBSERVATIONS
Authors: GOLDEN DBK KWITEROVICH KA KAGEYSOBOTKA A LICHTENSTEIN LM
Citation: Dbk. Golden et al., DISCONTINUING VENOM IMMUNOTHERAPY - EXTENDED OBSERVATIONS, Journal of allergy and clinical immunology, 101(3), 1998, pp. 298-305
RAGWEED-SPECIFIC ANTIBODIES IN BRONCHOALVEOLAR LAVAGE FLUIDS AND SERUM BEFORE AND AFTER SEGMENTAL LUNG CHALLENGE - IGE AND IGA ASSOCIATED WITH EOSINOPHIL DEGRANULATION
Authors: PEEBLES RS LIU MC ADKINSON NF LICHTENSTEIN LM HAMILTON RG
Citation: Rs. Peebles et al., RAGWEED-SPECIFIC ANTIBODIES IN BRONCHOALVEOLAR LAVAGE FLUIDS AND SERUM BEFORE AND AFTER SEGMENTAL LUNG CHALLENGE - IGE AND IGA ASSOCIATED WITH EOSINOPHIL DEGRANULATION, Journal of allergy and clinical immunology, 101(2), 1998, pp. 265-273
DAILY VARIATIONS OF SERUM DIAMINE OXIDASE LEVELS AND INFLUENCES OF H1AND H2 ANTIHISTAMINES ON PLACENTAL DIAMINE OXIDASE
Authors: KAGEYSOBOTKA A PROUD D SIEKIERSKI E LICHTENSTEIN LM WANTKE F
Citation: A. Kageysobotka et al., DAILY VARIATIONS OF SERUM DIAMINE OXIDASE LEVELS AND INFLUENCES OF H1AND H2 ANTIHISTAMINES ON PLACENTAL DIAMINE OXIDASE, Journal of allergy and clinical immunology, 101(1), 1998, pp. 397-397
DISCONTINUATION OF ANTI-IGE INFUSIONS RESTORES BASOPHIL (BASO) IGE AND FC-EPSILON-RI-ALPHA EXPRESSION, AND IGE-DEPENDENT HISTAMINE-RELEASE (HR) RESPONSES
Authors: SAINI S MACGLASHAN D ADELMAN D TOGIAS A LICHTENSTEIN LM BOCHNER BS
Citation: S. Saini et al., DISCONTINUATION OF ANTI-IGE INFUSIONS RESTORES BASOPHIL (BASO) IGE AND FC-EPSILON-RI-ALPHA EXPRESSION, AND IGE-DEPENDENT HISTAMINE-RELEASE (HR) RESPONSES, Journal of allergy and clinical immunology, 101(1), 1998, pp. 437-437
STING CHALLENGE TRIAL-I - SPECTRUM OF A POPULATION WITH STING ALLERGY
Authors: GOLDEN DBK KAGEYSOBOTKA A NORMAN PS LICHTENSTEIN LM
Citation: Dbk. Golden et al., STING CHALLENGE TRIAL-I - SPECTRUM OF A POPULATION WITH STING ALLERGY, Journal of allergy and clinical immunology, 101(1), 1998, pp. 657-657
DIFFERENTIAL REGULATION OF IL-4 AND IL-13 GENERATION FROM ANTIGEN-DRIVEN TH1 AND TH2 CLONES BY IFN-ALPHA
Authors: ESSAYAN DM BRAUN CM HAN WF ORIENTE A KAGEYSOBOTKA A LICHTENSTEIN LM KRISHNASWAMY G HUANG SK
Citation: Dm. Essayan et al., DIFFERENTIAL REGULATION OF IL-4 AND IL-13 GENERATION FROM ANTIGEN-DRIVEN TH1 AND TH2 CLONES BY IFN-ALPHA, Journal of allergy and clinical immunology, 101(1), 1998, pp. 674-674
PHARMACOLOGICAL EVIDENCE FOR MULTIPLE PATHWAYS IN THE INDUCTION OF IL-13 BY HUMAN BASOPHILS
Authors: SCHROEDER JT MACGLASHAN DW KAGEYSOBOTKA A LICHTENSTEIN LM
Citation: Jt. Schroeder et al., PHARMACOLOGICAL EVIDENCE FOR MULTIPLE PATHWAYS IN THE INDUCTION OF IL-13 BY HUMAN BASOPHILS, Journal of allergy and clinical immunology, 101(1), 1998, pp. 958-958
DIFFERENTIAL REGULATION OF IL-4 AND IL-13 SECRETION BY HUMAN BASOPHILS - THEIR RELATIONSHIP TO HISTAMINE-RELEASE IN MIXED LEUKOCYTE-CULTURES
Authors: REDRUP AC HOWARD BP MACGLASHAN DW KAGEYSOBOTKA A LICHTENSTEIN LM SCHROEDER JT
Citation: Ac. Redrup et al., DIFFERENTIAL REGULATION OF IL-4 AND IL-13 SECRETION BY HUMAN BASOPHILS - THEIR RELATIONSHIP TO HISTAMINE-RELEASE IN MIXED LEUKOCYTE-CULTURES, The Journal of immunology, 160(4), 1998, pp. 1957-1964
IN-VITRO REGULATION OF FC-EPSILON-RI-ALPHA EXPRESSION ON HUMAN BASOPHILS BY IGE ANTIBODY
Authors: MACGLASHAN D MCKENZIEWHITE J CHICHESTER K BOCHNER BS DAVIS FM SCHROEDER JT LICHTENSTEIN LM
Citation: D. Macglashan et al., IN-VITRO REGULATION OF FC-EPSILON-RI-ALPHA EXPRESSION ON HUMAN BASOPHILS BY IGE ANTIBODY, Blood, 91(5), 1998, pp. 1633-1643
COREGULATION OF ANTIGEN-SPECIFIC T-LYMPHOCYTE RESPONSES BY TYPE-I ANDTYPE-II CYCLIC-AMP-DEPENDENT PROTEIN-KINASES (CAK)
Authors: BRAUN CM HUANG SK KAGEYSOBOTKA A LICHTENSTEIN LM ESSAYAN DM
Citation: Cm. Braun et al., COREGULATION OF ANTIGEN-SPECIFIC T-LYMPHOCYTE RESPONSES BY TYPE-I ANDTYPE-II CYCLIC-AMP-DEPENDENT PROTEIN-KINASES (CAK), Biochemical pharmacology, 56(7), 1998, pp. 871-879
BILATERAL INCREASES IN HISTAMINE AFTER UNILATERAL NASAL ALLERGEN CHALLENGE
Authors: WAGENMANN M BAROODY FM CHENG CC KAGEYSOBOTKA A LICHTENSTEIN LM NACLERIO RM
Citation: M. Wagenmann et al., BILATERAL INCREASES IN HISTAMINE AFTER UNILATERAL NASAL ALLERGEN CHALLENGE, American journal of respiratory and critical care medicine, 155(2), 1997, pp. 426-431
DIFFERENTIAL REGULATION OF HUMAN, ANTIGEN-SPECIFIC TH1 AND TH2 RESPONSES BY THE B-7 HOMOLOGS, CD80 AND CD86
Authors: BASHIAN GG BRAUN CM HUANG SK KAGEYSOBOTKA A LICHTENSTEIN LM ESSAYAN DM
Citation: Gg. Bashian et al., DIFFERENTIAL REGULATION OF HUMAN, ANTIGEN-SPECIFIC TH1 AND TH2 RESPONSES BY THE B-7 HOMOLOGS, CD80 AND CD86, American journal of respiratory cell and molecular biology, 17(2), 1997, pp. 235-242
VESICULAR TRANSPORT OF CHARCOT-LEYDEN CRYSTAL PROTEIN IN F-MET PEPTIDE-STIMULATED HUMAN BASOPHILS
Authors: DVORAK AM MACGLASHAN DW WARNER JA LETOURNEAU L MORGAN ES LICHTENSTEIN LM ACKERMAN SJ
Citation: Am. Dvorak et al., VESICULAR TRANSPORT OF CHARCOT-LEYDEN CRYSTAL PROTEIN IN F-MET PEPTIDE-STIMULATED HUMAN BASOPHILS, International archives of allergy and immunology, 113(4), 1997, pp. 465-477
SERUM IGE LEVEL DRIVES BASOPHIL AND MAST-CELL IGE RECEPTOR DISPLAY
Authors: MACGLASHAN DW BOCHNER BS ADELMAN DC JARDIEU PM TOGIAS A LICHTENSTEIN LM
Citation: Dw. Macglashan et al., SERUM IGE LEVEL DRIVES BASOPHIL AND MAST-CELL IGE RECEPTOR DISPLAY, International archives of allergy and immunology, 113(1-3), 1997, pp. 45-47
CLINICAL AND IMMUNOLOGICAL EFFECTS OF COMPONENT PEPTIDES IN ALLERVAX(R) CAT
Authors: NORMAN PS NICODEMUS CF CRETICOS PS WOOD RA EGGLESTON PA LICHTENSTEIN LM KAGEYSOBOTKA A PROUD D
Citation: Ps. Norman et al., CLINICAL AND IMMUNOLOGICAL EFFECTS OF COMPONENT PEPTIDES IN ALLERVAX(R) CAT, International archives of allergy and immunology, 113(1-3), 1997, pp. 224-226
LOCALIZATION OF CHARCOT-LEYDEN CRYSTAL PROTEIN IN INDIVIDUAL MORPHOLOGICAL PHENOTYPES OF HUMAN BASOPHILS STIMULATED BY F-MET PEPTIDE
Authors: DVORAK AM MACGLASHAN DW WARNER JA LETOURNEAU L MORGAN ES LICHTENSTEIN LM ACKERMAN SJ
Citation: Am. Dvorak et al., LOCALIZATION OF CHARCOT-LEYDEN CRYSTAL PROTEIN IN INDIVIDUAL MORPHOLOGICAL PHENOTYPES OF HUMAN BASOPHILS STIMULATED BY F-MET PEPTIDE, Clinical and experimental allergy, 27(4), 1997, pp. 452-474
ANAPHYLAXIS DURING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL INFUSION
Authors: ESSAYAN DM SCHILDER R KAGEYSOBOTKA A JENKENS MK KORZENIOWSKI O LICHTENSTEIN LM KING ED
Citation: Dm. Essayan et al., ANAPHYLAXIS DURING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL INFUSION, Bone marrow transplantation, 19(7), 1997, pp. 749-752
DURATION OF VENOM IMMUNOTHERAPY - REPLY
Authors: GOLDEN DBK KWITEROVICH KA KAGEYSOBOTKA A VALENTINE MD LICHTENSTEIN LM
Citation: Dbk. Golden et al., DURATION OF VENOM IMMUNOTHERAPY - REPLY, Journal of allergy and clinical immunology, 99(2), 1997, pp. 272-272
MINIMAL TNF-ALPHA PRODUCTION FOLLOWING ACTIVATION OF PURIFIED HUMAN LUNG MAST-CELLS
Authors: REDRUP AC MACGLASHAN DW LICHTENSTEIN LM KAGEYSOBOTKA A SCHROEDER JT
Citation: Ac. Redrup et al., MINIMAL TNF-ALPHA PRODUCTION FOLLOWING ACTIVATION OF PURIFIED HUMAN LUNG MAST-CELLS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 355-355
PHARMACOLOGICAL REGULATION OF HISTAMINE-R ELEASE BY THE IGE-DEPENDENTHISTAMINE-RELEASING FACTOR (HRF)
Authors: BHEEKHAESCURA R CHANCE SR LANGDON JM LICHTENSTEIN LM MACGLASHAN DW MACDONALD SM
Citation: R. Bheekhaescura et al., PHARMACOLOGICAL REGULATION OF HISTAMINE-R ELEASE BY THE IGE-DEPENDENTHISTAMINE-RELEASING FACTOR (HRF), Journal of allergy and clinical immunology, 99(1), 1997, pp. 368-368
DIFFERENTIAL MODULATION OF T-CELL SUBSET RESPONSES BY CAMP-DEPENDENT PROTEIN-KINASE (CAK) ISOFORMS
Authors: ESSAYAN DM BRAUN CM HUANG SK KAGEYSOBOTKA A LICHTENSTEIN LM
Citation: Dm. Essayan et al., DIFFERENTIAL MODULATION OF T-CELL SUBSET RESPONSES BY CAMP-DEPENDENT PROTEIN-KINASE (CAK) ISOFORMS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 389-389
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>